Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

By LabMedica International staff writers
Posted on 06 Oct 2026

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. More...

Nontuberculous mycobacteria (NTM) are increasingly recognized as important causes of pulmonary disease, while mixed infections and strain-level variation can complicate standard testing. Current methods, including culture, mass spectrometry, and molecular assays, remain important but can be limited in multiplex species identification. A new commentary highlights a CRISPR-based approach designed to combine broad detection with species-level analysis.

Researchers from Shanghai Jiao Tong University School of Medicine discuss the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI) in LabMed Discovery. The commentary examines a platform originally developed by the research group and published in Science Translational Medicine. CANDI integrates broad-range amplification, species-specific CRISPR recognition, fluorescence encoding, and microfluidic droplet pairing within a single diagnostic architecture.

The platform uses a genome-informed design strategy. Its development included analysis of 103,332 Mycobacterium genomes to identify conserved regions in the 16S and 23S ribosomal RNA (rRNA) genes for broad-range amplification. Species-specific guide RNAs were then selected based on sequence differences between species, while also accounting for sequence conservation within target species.

This design is intended to support broad target coverage while preserving species-level specificity. It also aims to reduce missed detection linked to strain-level sequence variation. By separating amplification, molecular recognition, signal identity and spatial organization, CANDI offers a framework for scalable multiplex molecular detection without relying on increasingly complex multiplex primer designs.

The commentary also emphasizes CANDI’s ability to analyze mixed samples. The platform can identify multiple mycobacterial species simultaneously and was shown to resolve mixtures containing up to five species, including closely related organisms. In clinical evaluation, it detected some organisms not recovered by culture, which the authors suggest may reflect direct molecular analytical sensitivity or low-abundance organisms that are difficult to culture.

Further work is needed before CANDI can be used routinely in clinical laboratories. Key challenges include addressing genomic variation, interpreting low-abundance culture-independent detections in clinical context, and automating droplet generation, pairing, imaging and computational analysis. The authors identify development of a standardized sample-to-answer workflow as important for translating this type of multiplex molecular technology into clinical practice.

Related Links
Shanghai Jiao Tong University School of Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.